We further revealed that slow-cycling chemoresistant and radioresistant cancer cells exhibit elevated levels of lipid droplets and increased ferroptosis resistance and that combined treatment with ferroptosis inducers and DGAT inhibitors overcomes ferroptosis resistance and suppresses the growth of such therapy-resistant tumors. This evidence concerns the gene DGAT1 and cancer.